1. Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial. Issue 5 (15th January 2014) Authors: Smolen, J S; Emery, P; Ferraccioli, G F; Samborski, W; Berenbaum, F; Davies, O R; Koetse, W; Purcaru, O; Bennett, B; Burkhardt, H Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 5(2015) Page Start: 843 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗